Cirrhosis Risk Prediction in individuals with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

被引：0
|
作者：
Chun, Ji Sun [1 ,2 ]
Song, Yuri [1 ,2 ]
Lee, Woo Vin [1 ,2 ]
Ko, Minoh [1 ,2 ]
Jang, Ha Young [3 ]
Kim, In-Wha [1 ,2 ]
Kim, Hyunah [4 ]
Song, Yun-Kyoung [5 ]
Park, Sehoon [6 ]
Lee, Hajeong [6 ]
Lee, Hae-Young [6 ]
Kwak, Soo Heon [6 ]
Oh, Jung Mi [1 ,2 ]
机构：
[1] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
[2] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea
[3] Gachon Univ, Coll Pharm, Incheon, South Korea
[4] Sookmyung Womens Univ, Coll Pharm, Seoul, South Korea
[5] Catholic Univ Korea, Seoul, South Korea
[6] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1241
引用
收藏
页码：559 / 559
页数：1
相关论文
共 50 条
  • [41] Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
    Younossi, Zobair M.
    Gramlich, Terry
    Matteoni, Christi A.
    Boparai, Navdeep
    Mccullough, Arthur J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (03) : 262 - 265
  • [42] Nonalcoholic fatty liver disease is a risk factor for CKD in patients with type 2 diabetes
    不详
    Nature Clinical Practice Nephrology, 2008, 4 (11): : 584 - 584
  • [43] Nonalcoholic fatty liver disease is a risk factor for CKD in patients with type 2 diabetes
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 (11): : 593 - 593
  • [44] Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus
    Qian, Xiaoyi
    Wu, Wenwen
    Chen, Boyang
    Zhang, Simin
    Xiao, Chunmei
    Chen, Long
    Chen, Jun
    Ke, Lingli
    He, Meian
    Li, Xiulou
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
  • [45] NONALCOHOLIC FATTY LIVER DISEASE Liver disease: an overlooked complication of diabetes mellitus
    Arrese, Marco
    NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (12) : 660 - 661
  • [46] Sleep patterns, genetic susceptibility, and risk of cirrhosis among individuals with nonalcoholic fatty liver disease
    Qin, Shifan
    Cheng, Xiang
    Zhang, Shanshan
    Shen, Qian
    Zhong, Rong
    Chen, Xueqin
    Yi, Zhiqian
    HEPATOLOGY INTERNATIONAL, 2024, 18 (04) : 1158 - 1167
  • [47] Osteoporosis risk prediction in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
    Titova, Yu O.
    Misiura, K., V
    Kravchun, N. O.
    ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (05) : 637 - 642
  • [48] Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease
    Lin, X.
    Zhang, Z.
    Chen, J. M.
    Xu, Y. Y.
    Ye, H. R.
    Cui, J.
    Fang, Y.
    Jin, Y.
    Zhu, D. R.
    Yuan, L.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 2940 - 2946
  • [49] The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Yang, Yuxian
    Li, Shuting
    Xu, Yuechao
    Ke, Jing
    Zhao, Dong
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 1505 - 1515
  • [50] Treating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a review of efficacy and safety
    Mills, Elizabeth P.
    Brown, K. Paige D.
    Smith, Jennifer D.
    Vang, Phillip W.
    Trotta, Katie
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2018, 9 (01) : 15 - 28
12345